Volume 24, Issue 1 p. 104
Mutation in Brief
Free Access

A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes

Frédéric Leprêtre

Frédéric Leprêtre

CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France

Search for more papers by this author
Francis Vasseur

Francis Vasseur

CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France

Search for more papers by this author
Martine Vaxillaire

Martine Vaxillaire

CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France

Search for more papers by this author
Philipp E. Scherer

Philipp E. Scherer

Department of Cell Biology and Medicine, Division of Endocrinology and Diabetes Research and Training Center Albert Einstein College of Medicine, Bronx, NY

Search for more papers by this author
Saira Ali

Saira Ali

MRC Clinical Sciences Centre and Hammersmith Genome Centre, Hammersmith Hospital, London, UK

Search for more papers by this author
Kenneth Linton

Kenneth Linton

MRC Clinical Sciences Centre and Hammersmith Genome Centre, Hammersmith Hospital, London, UK

Search for more papers by this author
Timothy Aitman

Timothy Aitman

MRC Clinical Sciences Centre and Hammersmith Genome Centre, Hammersmith Hospital, London, UK

Search for more papers by this author
Philippe Froguel

Corresponding Author

Philippe Froguel

CNRS 8090-Institute of Biology, Pasteur Institute, Lille, France

Hammersmith Genome Centre and Genomic Medicine, Imperial College, Hammersmith Hospital, London, UK

Pasteur Institute of Lille, 1 rue Calmette, 59000, Lille, FranceSearch for more papers by this author
First published: 04 June 2004
Citations: 45

Communicated by Mark H. Paalman

Online Citation: Human Mutation, Mutation in Brief #727 (2004) Online http://www3.interscience.wiley.com/homepages/38515/pdf/mutation/727.pdf

Abstract

Mutations in CD36 / fatty acid translocase (FAT) gene are responsible for insulin resistance in the rat but contribution to human Type 2 diabetes is unknown. A nominal evidence for linkage of familial T2D at the CD36 locus led us to identify a rare nonsense mutation c.1079T>G (p.L360X) in one Caucasian pedigree presenting with autosomal dominant diabetes. Adiponectin levels, as marker of insulin sensitivity, were found to be significantly lower in the p.L360X variant carriers compared to homozygous for wild type CD36. Furthermore, expression studies of the truncated protein showed a defective binding of acetylated-LDL. Thus, our findings suggest a possible role for CD36 in the pathogenesis of T2D associated with reduced insulin sensitivity. © 2004 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.